NewKerala.com

Key Points

Sigachi Industries reported a 21% drop in net profit, with revenue also sliding in Q4. Despite these setbacks, CEO Amit Raj Sinha expressed optimism about future growth. He highlighted the company's strategic expansions and upcoming developments, like the Hyderabad API R&D center. Sigachi aims to deepen its footprint globally, entering new markets through partnerships and contracts.

Key Points: Sigachi Industries Faces 21% Profit Drop with Q4 Revenue Decline

  • Sigachi reports 21% profit drop, revenue down
  • CEO Amit Raj Sinha optimistic about future growth
  • Company expanding into Latin America and Southeast Asia
2 min read

Sigachi Industries reports 21 pc drop in net profit in Q4, revenue also declines

Sigachi Industries sees a 21% profit drop, with Q4 revenue also down. CEO bullish on future global growth.

"FY25 has been a transformative year for Sigachi. - Amit Raj Sinha, CEO"

Hyderabad, June 1

Sigachi Industries Limited has announced that the company’s net profit fell by approximately 21.16 per cent, coming down to Rs 16.17 crore in Q4 from Rs 20.51 crore in the previous quarter.

This dip comes alongside a decline in both revenue from operations and total income.

Revenue from operations in Q4 stood at Rs 128.2 crore, down from Rs 139.41 crore in the previous quarter -- a fall of about 8.04 per cent.

Total income also dropped to Rs 130.39 crore in Q4 compared to Rs 141.43 crore in Q3, marking a 7.81 per cent decrease.

Despite the quarter-on-quarter (QoQ) decline, the company remains optimistic about its growth prospects.

Commenting on the performance and outlook, Sigachi Industries Managing Director and CEO Amit Raj Sinha said: "FY25 has been a transformative year for Sigachi, marked by robust financial outcomes and strategic expansions across excipients and APIs."

"With our Hyderabad API R&D centre going live in Q1 FY26, regulatory approvals flowing in, and global market penetration deepening, we are positioned for sustainable high-margin growth," he said.

"Our 36-year legacy and diversified portfolio give us an unmatched advantage to scale operations globally while safeguarding profitability," he added.

"The company is expanding its footprint beyond India, the US, and Europe by aggressively entering Latin America, Southeast Asia, and the Middle East through new distribution partnerships and turnkey O&M contracts," Sigachi said in its filing.

Sigachi Industries, founded in 1989 and headquartered in Hyderabad, is a manufacturer in the field of pharma excipients, nutraceuticals, and food ingredients.

The company is known for its global leadership in the production of microcrystalline cellulose (MCC), with manufacturing facilities in India and subsidiaries operating internationally.

The company serves a broad spectrum of industries, including pharmaceuticals, food and beverages, nutraceuticals, and cosmetics.

- IANS

Share this article:

Reader Comments

R
Rahul K.
Not surprised by the dip in profits - the pharma sector has been facing challenges globally. But Sigachi has strong fundamentals and their international expansion plans look promising. Hope they bounce back stronger next quarter! 🇮🇳
P
Priya M.
As a small investor in Sigachi, I'm concerned about the 21% profit drop. The management sounds confident, but I wish they'd explained the reasons more clearly. Maybe global supply chain issues? Need more transparency.
S
Sanjay T.
Hyderabad's pharma hub continues to shine! Though numbers are down, Sigachi's R&D investment and global vision make it a long-term player. Their MCC products are world-class - this is just a temporary setback.
A
Ananya G.
Interesting to see an Indian company expanding in Latin America and Middle East markets. 🇮🇳 Make in India going global! The profit dip is concerning but their diversified portfolio should help weather the storm.
V
Vikram S.
The CEO's optimism sounds good on paper, but investors need to see concrete results. Maybe they're spreading too thin with all these global expansions? Focus on stabilizing domestic operations first.
N
Neha P.
As someone in the pharma industry, I know Sigachi's products have excellent quality. Quarterly fluctuations happen - what matters is their 36-year legacy and consistent innovation. Long-term investors shouldn't panic!

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50